TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33106853

Group type: EXPERIMENTAL
Intervention: Observational analysis; 1 kg/m2 increase in BMI
Number of subjects: 460397

Group type: EXPERIMENTAL
Intervention: Observational analysis; 1 µg/mL increase in plasma adiponectin
Number of subjects: 460397

Group type: EXPERIMENTAL
Intervention: One-sample Mendelian randomization; 1 kg/m2 genetically determined increase in BMI
Number of subjects: 460397

Group type: EXPERIMENTAL
Intervention: One-sample Mendelian randomization; 1 µg/mL genetically determined increase in plasma adiponectin
Number of subjects: 460397

Group type: EXPERIMENTAL
Intervention: Two-sample Mendelian randomization; corresponding estimates for BMI
Number of subjects: 460397

Group type: EXPERIMENTAL
Intervention: Two-sample Mendelian randomization; corresponding estimates for adiponectin
Number of subjects: 460397
Study: 36261813

Group type: EXPERIMENTAL
Intervention: HJD Formula Granules plus lifestyle intervention
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: HJD Elixation plus lifestyle intervention
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo plus lifestyle intervention
Number of subjects: 183
Study: 34733625

Group type: EXPERIMENTAL
Intervention: 22G needle
Number of subjects: 102

Group type: COMPARATOR
Intervention: 25G needle
Number of subjects: 102
Study: 35488724

Group type: EXPERIMENTAL
Intervention: Synovial fluid IL-6 concentrations
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Synovial fluid CTX-II concentrations
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Synovial fluid IL-1ß concentrations
Number of subjects: 23
Study: 33496964

Group type: EXPERIMENTAL
Intervention: Posttreatment reductions in WHO drinking risk levels
Number of subjects: 693
Study: 32641096

Group type: EXPERIMENTAL
Intervention: Anterior colporraphy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaginal patch plastron
Number of subjects: 0
Study: 34962022

Group type: EXPERIMENTAL
Intervention: Nurse-nurse collaboration (specifically conflict management subscale)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Self-perceived job performance
Number of subjects: 155
Study: 34468881

Group type: EXPERIMENTAL
Intervention: Initial invasive revascularization strategy with optimal medical therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimal medical therapy alone
Number of subjects: 0
Study: 35466074

Group type: EXPERIMENTAL
Intervention: Syndactylia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Closed reduction and intrinsic plus cast immobilisation
Number of subjects: 40
Study: 35377706

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 33964566

Group type: EXPERIMENTAL
Intervention: Generic self-disclaimer caption
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Specific self-disclaimer caption
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Warning self-disclaimer caption
Number of subjects: 311

Group type: COMPARATOR
Intervention: No caption (control group)
Number of subjects: 311
Study: 32512985

Group type: EXPERIMENTAL
Intervention: Home bleaching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diode laser bleaching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Plasma arc bleaching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: No light source in-office bleaching
Number of subjects: 60
Study: 36339195

Group type: EXPERIMENTAL
Intervention: Everyday discrimination during the pandemic
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Everyday discrimination before the pandemic
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Social support and social cohesion during the pandemic
Number of subjects: 165
Study: 33185602

Group type: EXPERIMENTAL
Intervention: Paired PLIÉ program (1 hour, 2 days/week, 12 weeks, 3 home visits)
Number of subjects: 30
Study: 616401931

Group type: EXPERIMENTAL
Intervention: Systematic diet guidance
Number of subjects: 112

Group type: COMPARATOR
Intervention: Routine diet guidance
Number of subjects: 112
Study: 37212758

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 466

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 466
Study: 33326255

Group type: EXPERIMENTAL
Intervention: Daratumumab, lenalidomide, and dexamethasone (D‐Rd)
Number of subjects: 737

Group type: COMPARATOR
Intervention: Lenalidomide and dexamethasone (Rd)
Number of subjects: 737
Study: 32359899

Group type: EXPERIMENTAL
Intervention: ticagrelor + aspirin
Number of subjects: 500

Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 500
Study: 35229778

Group type: EXPERIMENTAL
Intervention: Manual toothbrush (Oral‐B Pro Health Gum care®)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Powered toothbrush (Oral‐B Cross action Power Dual®)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Charcoal toothbrush (Colgate slim Soft Charcoal®)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All toothbrushes
Number of subjects: 60
Study: 32010948

Group type: EXPERIMENTAL
Intervention: Online interactive presentation formats (experimental condition)
Number of subjects: 1531

Group type: COMPARATOR
Intervention: Control condition (receiving no information)
Number of subjects: 1531

Group type: EXPERIMENTAL
Intervention: Experimental condition
Number of subjects: 1531

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1531
Study: 32020676

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (INT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Moderate-Continuous Training (CONT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both INT and CONT
Number of subjects: 28
Study: 35778941

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral-based physical therapy (CBPT) intervention, 6 sessions, telephone-based
Number of subjects: 112
Study: 34691747

Group type: EXPERIMENTAL
Intervention: Arpeggiated guitar pattern
Number of subjects: 180

Group type: COMPARATOR
Intervention: Bass/chord guitar pattern
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both accompaniment patterns
Number of subjects: 180
Study: 35906549

Group type: EXPERIMENTAL
Intervention: Combination of 30 Gy/5fx HSRT and 20 Gy/10fx IMRT with concurrent temozolomide and adjuvant chemotherapy
Number of subjects: 0
Study: 34192938

Group type: EXPERIMENTAL
Intervention: Largest possible modular femoral head (36 mm to 44 mm)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 32 mm head
Number of subjects: 96
Study: 32869579

Group type: EXPERIMENTAL
Intervention: MHF-like needling technique combined with Tuina manipulation
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional needling
Number of subjects: 72
Study: 36078655

Group type: EXPERIMENTAL
Intervention: Mostly Nonlinear (MNL; 20% linear, 80% nonlinear)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Mostly Linear (ML; 80% linear, 20% nonlinear)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control (C; conventional teaching from generalists)
Number of subjects: 183
Study: 32906135

Group type: EXPERIMENTAL
Intervention: Standard blood pressure treatment arm
Number of subjects: 2428

Group type: COMPARATOR
Intervention: Intensive blood pressure treatment arm
Number of subjects: 2428
Study: 34786992

Group type: EXPERIMENTAL
Intervention: Triamcinolone
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Triamcinolone plus Lidocaine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 55
Study: 32112909

Group type: COMPARATOR
Intervention: Fluoride-free dentifrice (nHA0)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0 ppm F- dentifrice (NaF0)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1100 ppm F- as NaF (NaF1100)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5000 ppm F- as NaF (NaF5000)
Number of subjects: 20
Study: 34213691

Group type: EXPERIMENTAL
Intervention: 4 t/ha MSWC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 8 t/ha MSWC
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 t/ha MSWC (unamended, control)
Number of subjects: 0
Study: 32594854

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR; 985 mg/d)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA; 0.37 mg/d)
Number of subjects: 15
Study: 32738298

Group type: EXPERIMENTAL
Intervention: Sample pooling approach for wide-scale population screening for COVID-19
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Automated RNA extraction followed by RT-PCR
Number of subjects: 940
Study: 35599701

Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation (enoxaparin or unfractionated heparins)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Low-dose anticoagulation in acutely ill participants/intermediate-dose anticoagulation in critically ill participants
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation
Number of subjects: 159

Group type: COMPARATOR
Intervention: Low/intermediate anticoagulation
Number of subjects: 159
Study: 34499665

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: HIV screening
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: HIV-TB screening
Number of subjects: 473
Study: 35639970

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (PrORT)
Number of subjects: 1390

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1390

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (PrORT) in SCC subgroup
Number of subjects: 1390

Group type: COMPARATOR
Intervention: Surgery alone in SCC subgroup
Number of subjects: 1390

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (PrORT) in AC subgroup
Number of subjects: 1390

Group type: COMPARATOR
Intervention: Surgery alone in AC subgroup
Number of subjects: 1390
Study: 34134434

Group type: EXPERIMENTAL
Intervention: Electronic waste exposure (Lead exposure)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Referent group (no electronic waste exposure)
Number of subjects: 187
Study: 32359267

Group type: EXPERIMENTAL
Intervention: Prototype violins made from fiber-reinforced polymers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of traditional wooden violins (implied)
Number of subjects: 0
Study: 36241477

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study: 33651090

Group type: EXPERIMENTAL
Intervention: Blinatumomab (2 cycles)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Chemotherapy (2 cycles)
Number of subjects: 208
Study: 32285242

Group type: EXPERIMENTAL
Intervention: Coaching support for implementation of evidence-based programs (EBPs)
Number of subjects: 40
Study: 616518461

Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5mg once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35305746

Group type: EXPERIMENTAL
Intervention: PACT-G
Number of subjects: 249

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 249
Study: 32750250

Group type: EXPERIMENTAL
Intervention: Liraglutide at a dose of 1.8 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orlistat, phentermine/topiramate, naltrexone/bupropion
Number of subjects: 0
Study: 36227352

Group type: EXPERIMENTAL
Intervention: THC-dominant cannabis (13.75 mg THC)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: THC/CBD-equivalent cannabis (13.75 mg THC/13.75 mg CBD)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: CBD-dominant cannabis (13.75 mg CBD)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 26
Study: 34155720

Group type: EXPERIMENTAL
Intervention: Pain educational video intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control condition (no video)
Number of subjects: 89
Study: 32577708

Group type: EXPERIMENTAL
Intervention: Audiovisual eyeglasses
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (eyes covered)
Number of subjects: 30
Study: 35737735

Group type: EXPERIMENTAL
Intervention: Physiologically based cord clamping (PBCC)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: PBCC
Number of subjects: 123

Group type: COMPARATOR
Intervention: ECC
Number of subjects: 123
Study: 33788464

Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment at Dahe (KI 12), Zhongzhu (KI 15), Hegu (LI 4), Xuehai (SP 10) for 30 min, once a day, for 2 courses with 1-day interval.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral Xinshenghua tablet, 4 tablets each time, 3 times a day for 7 days.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment
Number of subjects: 80
Study: 35038310

Group type: EXPERIMENTAL
Intervention: New care organization intervention involving case management, liaising with pediatric services, personalizing care pathways, and liaising with external structures.
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (patients transferred during the control period 04/2014-08/2016).
Number of subjects: 202
Study: 34464237

Group type: EXPERIMENTAL
Intervention: Pes-guided PEEP
Number of subjects: 200

Group type: COMPARATOR
Intervention: Empirical high PEEP
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PEEP titrated to end-expiratory transpulmonary pressure near 0 cm H2O
Number of subjects: 200
Study: 34318633

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 0.5 g dissolved in 20 ml normal saline injected into femoral bone marrow cavity for local treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tranexamic acid 20 minutes before operation, 15 mg/kg diluted in 250 ml sodium chloride injection, intravenous drip
Number of subjects: 100
Study: 32345916

Group type: EXPERIMENTAL
Intervention: Liposomal CBD (20 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonliposomal CBD (50 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35354430

Group type: EXPERIMENTAL
Intervention: Comprehensive pre-end stage kidney disease education (CPE)
Number of subjects: 544

Group type: COMPARATOR
Intervention: Usual clinical care supplemented by resources for kidney disease information
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Qualitative assessment through semi-structured interviews
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Post-kidney failure clinical, patient-centered and health services outcomes
Number of subjects: 544
Study: 32631081

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Multiple daily injection (MDI)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study: 35236397

Group type: EXPERIMENTAL
Intervention: Universal psychoeducation (safeTALK) and screening for suicide risk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internet-based Cognitive Behavioural Therapy (Reframe IT) for high-risk students
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness evaluation of the programme
Number of subjects: 0
Study: 34131763

Group type: EXPERIMENTAL
Intervention: Music therapy along with conventional management
Number of subjects: 3095

Group type: COMPARATOR
Intervention: Conventional management only
Number of subjects: 3095
Study: 36050653

Group type: EXPERIMENTAL
Intervention: Nivolumab after Temozolomide
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Temozolomide (50 mg/m2 for 3 months)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 18
Study: 33840806

Group type: EXPERIMENTAL
Intervention: Instructional video on NSICU nursing skills
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no video instruction)
Number of subjects: 70
Study: 616116613

Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by VA stabilization
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by disease activity
Number of subjects: 277

Group type: COMPARATOR
Intervention: Verteporfin photodynamic therapy (vPDT)
Number of subjects: 277
Study: 35083559

Group type: EXPERIMENTAL
Intervention: Novel balloon catheter dilation therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: 14-Fr ordinary urinary catheter dilation therapy
Number of subjects: 34
Study: 33460579

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin (hs-cTn) using the female-specific 99th percentile threshold
Number of subjects: 2073849

Group type: COMPARATOR
Intervention: Control conditions (not explicitly defined)
Number of subjects: 2073849
Study: 32819352

Group type: EXPERIMENTAL
Intervention: Additional written feedback on patient satisfaction combined with guided self-reflection
Number of subjects: 71

Group type: COMPARATOR
Intervention: Usual immediate formative multisource feedback from tutors, patients, and peers
Number of subjects: 71
Study: 35960119

Group type: EXPERIMENTAL
Intervention: Schumann resonance (SR) device + oxybutynin for 12 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Active-control group (oxybutynin only)
Number of subjects: 35
Study: 33787926

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard Behavioral Therapy (SBT)
Number of subjects: 105
Study: 32349117

Group type: EXPERIMENTAL
Intervention: 5 mg/d oral tropisetron
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10 mg/d oral tropisetron
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 20 mg/d oral tropisetron
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34758408

Group type: EXPERIMENTAL
Intervention: Infrared technology (AccuVein AV-500®) for PIVC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard teaching method for PIVC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of PIVC skill scores between groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both methods (Infrared technology and Standard teaching)
Number of subjects: 0
Study: 32590958

Group type: EXPERIMENTAL
Intervention: Integrated clinic-community child obesity intervention
Number of subjects: 270

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 270
Study: 35657762

Group type: EXPERIMENTAL
Intervention: Non-type O blood
Number of subjects: 544

Group type: COMPARATOR
Intervention: Type O blood
Number of subjects: 544
Study: 33162246

Group type: EXPERIMENTAL
Intervention: Urethral bulking agent injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 0
Study: 33151955

Group type: EXPERIMENTAL
Intervention: Intervention (low energy diet, exercise training, optimized treatment of hypertension, dyslipidemia, and diabetes)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control
Number of subjects: 62
Study: 35158086

Group type: EXPERIMENTAL
Intervention: New Nordic Diet (NND)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 33932226

Group type: EXPERIMENTAL
Intervention: Montessori classrooms (adapted to French public education)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Conventional classrooms
Number of subjects: 176
Study: 35452414

Group type: EXPERIMENTAL
Intervention: Trust in Nurses (TN) intervention group, n = 46
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine nursing control group, n = 46
Number of subjects: 92
Study: 34886393

Group type: EXPERIMENTAL
Intervention: high-sugar/low-fiber (HSLF) meals
Number of subjects: 87

Group type: COMPARATOR
Intervention: low-sugar/high-fiber (LSHF) meals
Number of subjects: 87
Study: 35331641

Group type: EXPERIMENTAL
Intervention: Veliparib (120 mg daily for 7 days/cycle) with carboplatin and paclitaxel
Number of subjects: 595

Group type: COMPARATOR
Intervention: Chemotherapy alone (investigator's choice of platinum doublet chemotherapy, up to 6, 21-day cycles)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Veliparib + carboplatin/paclitaxel
Number of subjects: 595

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 595
Study: 33059763

Group type: EXPERIMENTAL
Intervention: Informational video clip
Number of subjects: 107

Group type: COMPARATOR
Intervention: Participant information sheet
Number of subjects: 107
Study: 36481298

Group type: EXPERIMENTAL
Intervention: Canagliflozin (n=113)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Glimepiride (n=120)
Number of subjects: 233
Study: 33009052

Group type: EXPERIMENTAL
Intervention: Diaphragmatic Breathing (DB)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Postprandial Diaphragmatic Breathing (DB)
Number of subjects: 23
Study: 33234658

Group type: COMPARATOR
Intervention: T-piece
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV)
Number of subjects: 900
Study: 35713846

Group type: EXPERIMENTAL
Intervention: Combined physical exercise (3 sessions per week for 16 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study: 34380392

Group type: EXPERIMENTAL
Intervention: 10 mg triamcinolone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 20 mg triamcinolone
Number of subjects: 20
Study: 32657261

Group type: EXPERIMENTAL
Intervention: Higher uric acid level in patients with normal renal function
Number of subjects: 3284

Group type: EXPERIMENTAL
Intervention: Higher uric acid level in patients with abnormal renal function
Number of subjects: 3284

Group type: EXPERIMENTAL
Intervention: Normal renal function
Number of subjects: 3284
Study: 35876018

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase treatment (IVT) followed by endovascular treatment (EVT)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Endovascular treatment (EVT) alone
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Stent retriever with or without IVT
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Successful reperfusion
Number of subjects: 473
Study: 33288685

Group type: EXPERIMENTAL
Intervention: Low-dose endotoxin (LPS) injection
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: LPS treatment in mice
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Neutrophil depletion and multiplexed vascular proteomics
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: LPS-injected mice
Number of subjects: 10
Study: 32843515

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral pudendal nerve block (PNB) with 0.25% ropivacaine 10 mL
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral pudendal nerve block (PNB)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group with 10 mL saline
Number of subjects: 72